NCT02931188View on ClinicalTrials.gov

The Effect of Anacetrapib on Vascular Function and Arterial Stiffness

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Atherosclerotic Cardiovascular DiseaseVascular Disease
Interventions
DRUG

Anacetrapib

No drug administration will occur on this sub-study. Participants will receive treatment on the main trial HPS3/TIMI 55: REVEAL (NCT01252953)

DRUG

Statin

No drug administration will occur on this sub-study. Participants will receive treatment on the main trial HPS3/TIMI 55: REVEAL (NCT01252953)

DRUG

Placebo

No drug administration will occur on this sub-study. Participants will receive treatment on the main trial HPS3/TIMI 55: REVEAL (NCT01252953)

Trial Locations (1)

CB2 0QQ

Clinical Investigation Ward, Addenbrooke's Hospital, Cambridge

All Listed Sponsors
collaborator

British Heart Foundation Cambridge Centre of Excellence

UNKNOWN

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT02931188 - The Effect of Anacetrapib on Vascular Function and Arterial Stiffness | Biotech Hunter | Biotech Hunter